Company / Operating Income
IDEAYA Biosciences, Inc. Operating Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$159.3M
FY2025
5-year range
-$327.0M / -$35.3M
FY2021-FY2025
Trend
+51.3%
vs FY2024
Sector context
#119 of 204
Health Care
What the data says
At -$159M, IDEAYA Biosciences, Inc.'s operating income ranks #119 of 204 in the Health Care sector. Operating Income returned to growth in FY2025 after 2 years of decline, reaching -$159M.
Based on SEC 10-K filings.
-$159M in FY2025.
Declined from -$134M to -$159M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#119 of 204 in Health CareTop 58% of 204This company -$159.3M Sector average $107.8M
▼
-247.9% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 51.3% year-over-year.
- Ranks #119 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2017.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$159.3M | +51.3% |
| FY2024 | -$327.0M | -143.2% |
| FY2023 | -$134.4M | -280.3% |
| FY2022 | -$35.3M | +20.2% |
| FY2021 | -$44.3M | -21.6% |
| FY2020 | -$36.4M | +17.7% |
| FY2019 | -$44.3M | -21.6% |
| FY2018 | -$36.4M | -152.2% |
| FY2017 | -$14.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026